United States · FDA National Drug Code directory
WELIREG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5331_120e5731-72fe-484f-ace4-5db35454a286
- Product NDC
- 0006-5331
- Form
- TABLET, FILM COATED
- Composition / generic term
- belzutifan
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210813
- Source listing expiry
- 20271231
Source-listed ingredients
- BELZUTIFAN — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01) · 0006-5331-01
- 1 BOTTLE in 1 CARTON (0006-5331-58) / 90 TABLET, FILM COATED in 1 BOTTLE · 0006-5331-58
- 1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE · 0006-5331-59
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →